These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 3672299)
21. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats. Gomi T; Ikeda T; Ishimitsu T; Uehara Y Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):139-44. PubMed ID: 2608692 [TBL] [Abstract][Full Text] [Related]
22. Beneficial effect of thromboxane A2 synthetase inhibitor (OKY-046) on 24-hr simple hypothermic preservation of the canine pancreas graft. Nagami H; Tamura K; Kin S; Teramoto M; Ishida T Int Surg; 1995; 80(3):274-7. PubMed ID: 8775620 [TBL] [Abstract][Full Text] [Related]
23. Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome. Niwa T; Maeda K; Shibata M; Yamada K Clin Nephrol; 1988 Nov; 30(5):276-81. PubMed ID: 3214971 [TBL] [Abstract][Full Text] [Related]
25. [Changes of prostaglandins in kidney tissue in gentamicin-induced acute renal tubular injury in rats]. Yu Y; Zheng F; Bo Y; Duan J; Huang H Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Feb; 20(1):38-43. PubMed ID: 11367732 [TBL] [Abstract][Full Text] [Related]
26. Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury. Simpson PJ; Smith CB; Rosenthal G; Lucchesi BR J Pharmacol Exp Ther; 1986 Aug; 238(2):497-501. PubMed ID: 3735129 [TBL] [Abstract][Full Text] [Related]
27. Effects of FK3311 on pulmonary ischemia-reperfusion injury in a canine model. Sunose Y; Takeyoshi I; Tsutsumi H; Kawata K; Tokumine M; Iwazaki S; Tomizawa N; Ohwada S; Matsumoto K; Morishita Y J Surg Res; 2001 Feb; 95(2):167-73. PubMed ID: 11162041 [TBL] [Abstract][Full Text] [Related]
28. Role of thromboxane A2 and prostacyclin in uninephrectomy-induced attenuation of ischemic renal injury. Kato A; Hishida A; Nakajima T Kidney Int; 1995 Nov; 48(5):1577-83. PubMed ID: 8544417 [TBL] [Abstract][Full Text] [Related]
29. Effects of selective thromboxane synthetase inhibitor OKY-046 on plasma prostaglandins in patients with coronary artery disease during exercise. Shikano M; Ogawa K; Ito T; Chen LS; Ito Y; Imaizumi M; Uno T; Tsutsumi S; Satake T Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():375-7. PubMed ID: 3159226 [No Abstract] [Full Text] [Related]
30. Effects of a selective inhibitor of thromboxane synthetase (OKY-1581) in humans. Ito T; Ogawa K; Sakai K; Watanabe J; Satake T; Kayama N; Hiraku S; Naito J Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():245-51. PubMed ID: 6221531 [No Abstract] [Full Text] [Related]
31. Sulindac does not spare renal prostaglandins. Waslen TA; McCauley FA; Wilson TW Clin Invest Med; 1989 Apr; 12(2):77-81. PubMed ID: 2650941 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome. Zipser RD; Kronborg I; Rector W; Reynolds T; Daskalopoulos G Gastroenterology; 1984 Dec; 87(6):1228-32. PubMed ID: 6593268 [TBL] [Abstract][Full Text] [Related]
34. Thromboxane synthetase inhibition decreases polymorphonuclear leukocyte activation following hindlimb ischemia. Cambria RA; Anderson RJ; Dikdan G; Lysz TW; Hobson RW II Am Surg; 1991 Feb; 57(2):76-9. PubMed ID: 1847027 [TBL] [Abstract][Full Text] [Related]
35. Clinical study on effect of thromboxane A2 synthetase inhibitor (OKY-046) to clarify the regulation of cerebral blood flow in cerebral thrombosis. Nihei C; Metoki H; Shimanaka Y; Kawahara R; Komatsu O; Oike Y; Kanazawa T; Izawa M; Kaneko H; Hoshi Y Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():953-7. PubMed ID: 2960210 [No Abstract] [Full Text] [Related]
36. Suppression of cytokine production by thromboxane A2 inhibitor in liver ischemia. Sugawara Y; Harihara Y; Takayama T; Makuuchi M Hepatogastroenterology; 1998; 45(23):1781-6. PubMed ID: 9840148 [TBL] [Abstract][Full Text] [Related]
37. [Effect of the recombinant staphylokinase on pancreatic ischemia in severe acute pancreatitis of rats]. Sha JP; Xue YM; Chen X; Zhu BD; Zhang XS; Chen WY; Feng BH; Zhao Y Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Aug; 19(8):467-70. PubMed ID: 17708840 [TBL] [Abstract][Full Text] [Related]
38. The protective effect of thromboxane A2 synthetase inhibitor against ischemic liver injury. Isozaki H; Okajima K; Hara H; Kobayashi M Surg Today; 1994; 24(5):435-40. PubMed ID: 8054815 [TBL] [Abstract][Full Text] [Related]
39. Effect of a thromboxane synthetase inhibitor on eicosanoid synthesis and glomerular injury during acute unilateral glomerulonephritis in the rat. Cook HT; Cattell V; Smith J; Salmon JA; Moncada S Clin Nephrol; 1986 Oct; 26(4):195-202. PubMed ID: 3490944 [TBL] [Abstract][Full Text] [Related]
40. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism. Dale J; Thaulow E; Myhre E; Parry J Thromb Haemost; 1983 Oct; 50(3):703-6. PubMed ID: 6689091 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]